By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces Formalization Of Buccal Cannabis Co-Development Plan 9/2/2015 10:12:43 AM
Generex Biotechnology Corporation (GNBT) Announces Issuance of Buccal Insulin White Paper 8/27/2015 9:15:13 AM
Generex Biotechnology Corporation (GNBT) Provides Update On Success Of Buccal Insulin Formulation Enhancement Project 8/25/2015 10:24:24 AM
Generex Biotechnology Corporation (GNBT) Announces Capital Investment 6/25/2015 11:31:58 AM
Generex Biotechnology Corporation (GNBT) Announces Collaboration With NHTherapeutics To Utilize The RapidMist Buccal Delivery Technology For Leuprolide 5/26/2015 7:41:17 AM
Generex Biotechnology Corporation (GNBT) Provides Data Update From AE37 Phase II Breast Cancer Trial One Year Post Completion Of Enrollment 5/14/2015 7:41:08 AM
Generex Biotechnology Corporation (GNBT) Announces Intention To Dividend A Portion Of Anticipated SMFI Securities To Its Stockholders Upon A Reverse Stock Split 5/4/2015 7:46:23 AM
Generex Biotechnology Corporation (GNBT) Announces New $11 Million Collaboration On Buccal Cannabis 4/23/2015 11:26:26 AM
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Data Correlating Immune Response With Reduction Of Relapse In AE37 Phase II Breast Cancer Trial At AACR 2015 4/21/2015 11:41:32 AM
Generex Biotechnology Corporation (GNBT) Acknowledges the Contributions Of Its Chairman 4/8/2015 6:41:31 AM
12345678910...
//-->